TY  - CONF

T1  - 2510 3-year follow-up of chemotherapy following radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients (Pts) with symptomatic bone metastases (Mets) from ALSYMPCA

JO  - European Journal of Cancer

PY  - 2015/09/01

AU  - Sartor O

AU  - Coleman RE

AU  - Nilsson S

AU  - Vogelzang NJ

AU  - Staudacher K

AU  - Thuresson M

AU  - Parker C

ED  - 

DO  - DOI: 10.1016/s0959-8049(15)30047-2

PB  - Elsevier BV

VL  - 51

SP  - S477

EP  - S477

Y2  - 2025/10/10

ER  -